Universal newborn hearing screening programs

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 6, Issue 5, 1998, Pages 346-351

  Culpepper, Brandt ^a  

^a GALLAUDET UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN STEM RESPONSE; CONGENITAL DEAFNESS; COST BENEFIT ANALYSIS; EVOKED OTOACOUSTIC EMISSION; GENETIC DISORDER; HUMAN; NEWBORN; NEWBORN PERIOD; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCREENING;

EID: 0031725812     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-199810000-00013     Document Type: Review

References (38)

1. National Institutes of Health: Consensus Statement. Early Identification of Hearing Impairment in Infants and Young Children; March, 1993.
2. Johnson JL, Kuntz NL, Sia CC, White KR, Johnson RL: Newborn hearing screening in Hawaii. Hawaii Med J 1997, 56:352-355. This article demonstrates success in identifying congenital hearing loss and providing necessary services to infants, young children, and their families for developing age-appropriate developmental and communication skills. A tribute to support and collaboration of legislators, pediatricians, hospital staff, and department of health personnel.
3. Healthy People 2000. U.S. Department of Health and Human Services, Public Health Service, DHHS Publication (PHS) 91-50213. Washington, DC: U.S. Government Printing Office; 1990.
4. American Speech-Language-Hearing Association: Joint Committee on Infant Hearing Position Statement 1994, 34:38-41.
5. Culpepper NB: Neonatal screening via evoked otoacoustic emissions. In Otoacoustic Emissions: Clinical Applications. Edited by Robinette MS, Glattke TJ. New York: Thieme; 1997:233-270.
6. Kim DO, Sun XM, Jung MD, Leonard G: A new method of measuring distortion product otoacoustic emissions using multiple tone pairs: study of human adults. Ear Hear 1997, 18:277-285.
7. Slaven A, Thornton AR: Neonatal otoacoustic emissions recorded using maximum length sequence stimuli. Ear Hear 1998, 19:103-110.
8. McKinley AM, Grose JH, Roush J: Multifrequency tympanometry and evoked otoacoustic emissions in neonates during the first 24 hours of life. J Am Acad Audiol 1997, 8:218-223.
9. Chang KW, Vohr BR, Norton SJ, Lekas MD: External canal and middle ear status related to evoked otoacoustic emissions in neonates. Arch Otolaryngol Head Neck Surg 1993, 119:276-282.
10. Maxon AB, White KR, Culpepper B, Vohr BR: Maintaining acceptably low referral rates in TEOAE-based newborn hearing screening programs. J Commun Disord 1997, 30:457-475.
11. Penn TO: Infant hearing screening: status and current concepts. Curr Opin Otolaryngol Head Neck Surg 1997, 5:312-316.
12. Kugelman A, Hadad B, Ben-David J, Pososhin L, Borochowitz Z, Bader D: Preauricular tags and pits in the newborn: the role of hearing tests. Acta Paediatr 1997, 86:170-172.
13. Mauk GW, White KR, Mortensen LB, Behrens TR: The effectiveness of screening programs based on high-risk characteristics in early identification of hearing impairment. Ear Hear 1991, 12:312-319.
14. Vartiainen E, Karjalainen S: Congenital and early-onset bilateral hearing impairment in children: The delay in detection. J Laryngol Otol 1997, 111:1018-1021. In this study from Finland, 39% of children with hearing loss were identified before 2 years of age. The study showed that high-risk behavioral screenings are insufficient, and demonstrates the need to use objective screening despite higher cost. More severe hearing loss is easier to treat if identified earlier.
15. Kounlakis SD, Psifidis A, Chang CJ, Stiernberg CM: Risk factors associated with hearing loss in neonates. Am J Otolaryngol 1997, 18:90-93.
16. Lutman ME, Davis AC, Fortnum HM, Wood S: Field sensitivity of targeted neonatal hearing screening by transient-evoked otoacoustic emissions. Ear Hear 1997, 18:265-276. This study further investigates false positive and false negative results, where infants pass initial screening at birth, and later are determined to have hearing loss (conductive, sensorineural, mixed).
17. Fowler DB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF: Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997, 130:624-630. Study to determine prevalence and stability of sensorineural hearing loss with asymptomatic cytomegalovirus. Results suggest that delayed-onset and progressive hearing loss can be presented by young children with asymptomatic congenital cytomegalovirus. Asymptomatic ctyomegalovirus infection is likely to be a leading cause of sensorineural hearing loss among young children.
18. Haagerup A, Andersen JB, Blichfeldt S, Christensen MF: Biotinidase deficiency: two cases of very early presentation. Dev Med Child Neurol 1997, 39:832-835. Biotinase deficiency could cause severe central nervous system pathologies if undetected and untreated. Hearing loss is one component of sequella.
19. Graziani LJ, Gringlas M, Baumgart S: Cerebrovascular complications and neurodevelopmental sequelae of neonatal ECMO. Clin Perinatol 1997, 24:655-675. Follow-up evaluations are essential due to the high risk of delayed onset hearing loss. Auditory brainstem response results suggesting hearing within normal limits are not predictive of later auditory status. Follow-up is recommended.
20. Desai S, Kollros PR, Graziani LJ, Streletz LF, Goodman M, Stanley C, Cullen J, Baumgart S: Sensitivity and specificity of the neonatal brainstem auditory evoked potential for hearing and language deficits in survivors of extracorporeal membrane oxygenation. J Pediatr 1997, 131:233-239.
21. Lasky RE, Wiorek L, Becker TR: Hearing loss in survivors of neonatal extracorporeal membrane oxygenation (ECMO) therapy and high frequency oscillatory (HFO) therapy. J Am Acad Audiol 1998, 9:47-58.
22. Sweitzer RS, Lowry JK, Georgeson KE, Nelson KG, Johnson SE: Hearing loss associated with neonatal ECMO: a clinical investigation. Int J Pediatr Otorhinolaryngol 1997, 41:339-345.
23. Matkin ND, Diefendorf AO, Erenberg A: Children: HIV/AIDS and hearing loss. Semin Hear 1998, 19:165-176.
24. Fujikawa S, Yang L, Waffarn F, Lerner M: Persistent pulmonary hypertension of the newborn (PPHN) treated with inhaled nitric oxide: preliminary hearing outcomes. J Am Acad Audiol 1997, 8:263-268. Newborns receiving inhaled nitric oxide for persistent pulmonary hypertension do not (to date) appear to develop delayed hearing loss,
25. Abrams MJ, Pensak ML, Buhrer K: Perspectives on a state enacted hearing screening assessment program in the newborn population. Am J Otol 1997, 18:368-372. Trouble with follow-up persists for high-risk registries.
26. Thomson V: The Colorado newborn hearing screening project. Am J Audiol 1997, 6:74-77.
27. Prieve BA: Establishing infant hearing programs in hospitals. Am J Audiol 1997, 6:84-87.
28. Albright K, Finitzo T: Texas hospitals' quality control approach to universal infant hearing detection. Am J Audiol 1997, 6:88-90.
29. deMaddalena H, Reich K, Arold R: Significance of parental variables of early detection of pediatric hearing loss. HNO 1997, 45:30-35.
30. Mason JA, Herrmann KR: Universal infant hearing screening by automated auditory brainstem response measurement. Pediatrics 1998, 101:221-228.
31. Mehl, AL, Thomson, V Newborn hearing screening: the great omission. Pediatrics 1998, 101:E4. Comprehensive review of the status and progress made in UNHS in Colorado. Provides program statistics and cost information often sought by administrators.
32. Weirather Y, Korth N, White KR, Downs D, Woods-Kershner N: Cost analysis of TEOAE-based universal newborn hearing screening. J Commun Disord. Cited in White KR: Realities, myths, and challenges of newborn hearing screening in the United States. Am J Audiol 1997 6:95-99.
33. Weirather Y, Korth N, White KR, Downs D, Woods-Kershner N: Cost analysis of TEOAE-based universal newborn hearing screening. J Commun Disord. Cited in White KR: Realities, myths, and challenges of newborn hearing screening in the United States. Am J Audiol 1997 6:95-99.
34. Travis J: Genes of silence: scientists track down a slew of mutated genes that cause deafness. Science News 1998, 153:42-44. Informative review of genes that have been identified that cause deafness. It is written in terminology that professionals who are not microbiologists can understand.
35. Pennis E: The architecture of hearing. Science 1997, 278:1223-1224. This article provides insight into the advancements that can be made in our understanding of the anatomy and physiology of hearing through genetics. This article is written in terms that can be understood by professionals from many different fields and backgrounds.
36. Jarvelin MR, Maki-Torkko E, Sorri MJ, Rantakallio PT: Effect of hearing impairment on educational outcomes and employment up to the age of 25 years in northern Finland. Br J Audiol 1997, 31:165-175.
37. Newman CW, Jacobson GP, Hug GA, Sandridge SA: Perceived hearing handicap of patients with unilateral or mild hearing loss. Ann Otol Rhinol Laryngol 1997, 106:210-214.
38. Hindley P: Psychiatric aspects of hearing impairment. J Child Psychol Psychiatry 1997, 38:101-117.